|
38
|
87
|
4wzxA |
Ulk3 regulates cytokinetic abscission by phosphorylating escrt-iii proteins |
|
86
|
273
|
4wnoA |
Structure of ulk1 bound to an inhibitor |
|
83
|
297
|
4x7jA |
Co-crystal structure of perk with 2-amino-n-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor |
|
80
|
288
|
4x3fC |
Crystal structure of the intracellular domain of the m. tuberculosis ser/thr kinase pkna |
|
106
|
396
|
4wotA |
Rock2 in complex with 1426382-07-1 |
|
81
|
274
|
4wnpA |
Structure of ulk1 bound to a potent inhibitor |
|
95
|
291
|
4w8eA |
Structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06645342) |
|
79
|
267
|
4uynA |
Sar156497 an exquisitely selective inhibitor of aurora kinases |
|
66
|
256
|
4x7qA |
Pim2 kinase in complex with compound 1s |
|
95
|
329
|
4umqA |
Structure of melk in complex with inhibitors |
|
86
|
298
|
4x7lA |
Co-crystal structure of perk bound to 4-{2-amino-4-methyl-3-[2-(methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3h-pyrazol-3-one inhibitor |
|
92
|
317
|
4wsqA |
Crystal structure of adaptor protein 2 associated kinase (aak1) in complex with small molecule inhibitor |
|
79
|
273
|
4ty1A |
Crystal structure of human pim-1 kinase in complex with an aminooxadiazole-indole inhibitor. |
|
67
|
273
|
4rzvA |
Crystal structure of the braf (r509h) kinase domain monomer bound to vemurafenib |
|
107
|
333
|
4ubaA |
Low-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) |
|
110
|
334
|
4ub7A |
High-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) showing an extreme distortion of the atp-binding loop combined with a pi-halogen bond |
|
82
|
295
|
4u3zA |
Apo map4k4 t181e phosphomimetic mutant |
|
77
|
235
|
4tlbA |
Crystal structure of n-terminal c1 domain of kaic |
|
97
|
293
|
4u97A |
Crystal structure of asymmetric irak4 dimer |
|
83
|
295
|
4u42A |
Map4k4 t181e mutant bound to inhibitor compound 1 |
|
91
|
294
|
4tw9A |
Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of ck1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation |
|
98
|
292
|
4tn6A |
Ck1d in complex with inhibitor |
|
71
|
273
|
4rzwA |
Crystal structure of braf (r509h) kinase domain bound to az628 |
|
88
|
276
|
4txcA |
Crystal structure of dapk1 kinase domain in complex with a small molecule inhibitor |
|
130
|
419
|
4uakA |
Mrck beta in complex with adp |
|
80
|
271
|
4rvlA |
Chk1 kinase domain with diazacarbazole compound 7: 3-(2-hydroxyphenyl)-9h-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile |
|
105
|
294
|
4twcA |
2-benzamido-n-(1h-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of ck1d/e |
|
78
|
236
|
4tleA |
Crystal structure of n-terminal c1 domain of kaic |
|
79
|
271
|
4rvmA |
Chk1 kinase domain with diazacarbazole compound 19 |
|
99
|
350
|
4tyhA |
Ternary complex of p38 and mk2 with a p38 inhibitor |
|
94
|
290
|
4u8zA |
Crystal structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06447475) |
|
81
|
298
|
4u43A |
Map4k4 in complex with inhibitor (compound 6) |
|
78
|
233
|
4tlaA |
Crystal structure of n-terminal c1 domain of kaic |
|
79
|
234
|
4tlcA |
Crystal structure of n-terminal c1 domain of kaic |
|
82
|
295
|
4u41A |
Map4k4 bound to inhibitor compound 1 |
|
77
|
235
|
4tldA |
Crystal structure of n-terminal c1 domain of kaic |
|
81
|
234
|
4tl7A |
Crystal structure of n-terminal c1 domain of kaic |
|
82
|
296
|
4rvtA |
Map4k4 in complex with a pyridin-2(1h)-one derivative |
|
88
|
295
|
4u40A |
Mitogen-activated protein kinase kinase kinase kinase 4 (map4k4) bound to amppnp |
|
77
|
236
|
4tl9A |
Crystal structure of n-terminal c1 domain of kaic |
|
86
|
293
|
4u9aA |
Sulphur anomalous crystal structure of asymmetric irak4 dimer |
|
123
|
403
|
4u6rA |
Crystal structure of human ire1 cytoplasmic domains in complex with a sulfonamide inhibitor. |
|
93
|
300
|
4u45A |
Map4k4 in complex with inhibitor (compound 25) |
|
80
|
302
|
4tptA |
Crystal structure of the human limk2 kinase domain in complex with a non-atp competitive inhibitor |
|
80
|
238
|
4tl6A |
Crystal structure of n-terminal domain of kaic |
|
74
|
234
|
4tl8A |
Crystal structure of n-terminal c1 domain of kaic |
|
127
|
419
|
4ualA |
Mrck beta in complex with bdp00005290 |
|
88
|
299
|
4u44A |
Map4k4 in complex with inhibitor (compound 16) |
|
99
|
295
|
4u3yA |
Apo mitogen-activated protein kinase kinase kinase kinase 4 (map4k4) |
|
85
|
271
|
4rvkA |
Chk1 kinase domain with diazacarbazole compound 8: n-[3-(6-cyano-9h-pyrrolo[2,3-b:5,4-c']dipyridin-3-yl)phenyl]acetamide |
